Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Filings indexed 252 across all filing types
Latest filing 2023-10-23 Regulatory Filings
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2023-10-23 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a news release announcing the closing of a private placement by Ovation Science Inc. It details the number of units issued, the price per unit, gross proceeds, commissions paid, and warrants issued. There is no financial statement, detailed financial analysis, or regulatory certification present. The content focuses on fundraising activity and capital structure changes. The document length is short (2317 characters), and it is not a report or a certification but an announcement of a financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-10-18 English
News release - English.pdf
Regulatory Filings
2023-10-12 English
News release - English.pdf
Regulatory Filings
2023-10-03 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-08-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.